ARCT vs CLOV
Arcturus Therapeutics Holdings Inc (ARCT) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ARCT currently screens at market cap $369.4M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ARCT and CLOV stock pages for the full models.
Not investment advice.